RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Total cash & short-term investments

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndTotal cash & short-term investments (Million USD)YoY (%)
Dec 31, 20245,555-56.66%
Dec 31, 202312,816+38.87%
Dec 31, 20229,229-6.11%
Dec 31, 20219,830+15.93%
Dec 31, 20208,479-78.76%
Dec 31, 201939,924+395.27%
Dec 31, 20188,061-17.65%
Dec 31, 20179,789+52.41%
Dec 31, 20166,423-23.60%
Dec 31, 20158,407+0.39%
Dec 31, 20148,374-15.37%
Dec 31, 20139,895

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)